Patient-Specific Dose Adjustment in the Cancer Clinical Trial Setting

Author： Rogatko André   Ghosh Pulak   Vidakovic Brani   Tighiouart Mourad  

Publisher： Adis International

ISSN： 1178-2595

Source： Pharmaceutical Medicine, Vol.22, Iss.6, 2008-01, pp. : 345-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Extrathoracic Deposition Models for Patient-Specific Dose Estimation during Inhaler Design

By  

Current Pharmaceutical Design, Vol. 21, Iss. 27, 2015-01 ,pp. : 3984-3992

Bentham Science Publishers

Access to resources Recommend Favorite

A Standard Weight Descriptor for Dose Adjustment in the Obese Patient

By Stephen B. Duffull  

Clinical Pharmacokinetics, Vol. 43, Iss. 15, 2004-01 ,pp. : 1167-1178

Adis International

Access to resources Recommend Favorite

Patient-Specific Alpha-Particle Dosimetry

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 4, 2011-10 ,pp. : 329-335

Bentham Science Publishers

Access to resources Recommend Favorite

Alternative Views On Setting Clinical Trial Futility Criteria

By      

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 5, 2014-09 ,pp. : 976-993

Taylor & Francis Ltd

Access to resources Recommend Favorite

Effect of a Simple Dose-Escalation Schedule on Tramadol Tolerability: Assessment in the Clinical Setting

By I. Tagarro  

Clinical Drug Investigation, Vol. 25, Iss. 1, 2005-01 ,pp. : 23-31

Adis International

Access to resources Recommend Favorite